Etretinate

Etretinate (trade name Tegison®) is a medication used to treat severe psoriasis. It was removed from the United States market in 1998 and the Canadian market in 1996, due to the high risk of birth defects.

Precautions

 * Etretinate is a teratogen, and may cause birth defects long after use. Therefore, etretinate should only be used if one is never to get pregnant.
 * Etretinate should be avoided in children, as it may interfere with growth of bone.

Side effects

 * Hepatitis
 * Pseudotumor cerebri

Etretinaat